Gemella endocarditis: A case report and a review of the literature

Abstract

Infective endocarditis (IE) remains a prevalent disease with a high rate of morbidity and mortality. Recent changes have been noted in the profile of causative microorganisms. In this report, we describe a case of Gemella-related endocarditis and review the related literature. Our patient was an 81-year-old man who presented with dyspnea and fatigue. His initial examination revealed a new systolic murmur. Echocardiogram revealed moderate mitral regurgitation with 1-cm mass on the anterior mitral leaflet, and blood cultures grew Gemella haemolysans. Penicillin and gentamicin were initiated, and workup for possible source was positive for a colonic polyp with high-grade dysplasia. The patient subsequently developed cardiogenic shock and severe pulmonary edema. Comfort care measures were initiated, and he passed away thereafter. We reviewed PubMed for cases of Gemella-related endocarditis. We found 65 documented cases and added our patient’s case to the analysis. Seventy-two percent of the cases occurred in men. The mean age was 51 years and 42% of the patients were older than 60 years. Fever was the most common presenting symptom and most of the cases presented subacutely. The mitral valve was the most affected site and 50% of the patients required surgical intervention. G. morbillorum was the most common subtype and a total of four cases were found to be associated with colorectal neoplasm. As a conclusion, Gemella species rarely cause IE. The absence of a clear source of bacteremia warrants further evaluation for a gastrointestinal source. The infection can be destructive and must be promptly treated to avoid complications.

morbillorum Key messages: Gemella endocarditis is a serious infection with significant morbidity and mortality. It must be promptly treated to avoid further complications.

Keywords

Endocarditis - Gemella haemolysans - mitral - regurgitation

Publication History

Article published online:
09 August 2021

• References

• 1 Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A. et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 2015; 65: 2070-6
• 2 Ternhag A, Cederström A, Törner A, Westling K. A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS One 2013; 8: e67519
• 3 Sinha S, Bin Abdulhak AA, Baddour LM, Erwin PJ, Chu VH, Mensah GA. et al. Global and regional burden of infective endocarditis, 1990-2010: A systematic review of the literature. Glob Heart 2014; 9: 131-43
• 4 Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001; 345: 1318-30
• 5 Furrer H, Malinverni R. [Clinical aspects and diagnosis of infectious endocarditis]. Praxis (Bern 1994) 1994;83:1309-15.
• 6 Li JS, Sexton DJ, Mick N, Nettles R, Fowler VGJr. et al Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-8
• 7 McDonald JR. Acute infective endocarditis. Infect Dis Clin North Am 2009; 23: 643-64
• 8 Dhawan VK. Infective endocarditis in elderly patients. Clin Infect Dis 2002; 34: 806-12
• 9 Vogkou CT, Vlachogiannis NI, Palaiodimos L, Kousoulis AA. The causative agents in infective endocarditis: A systematic review comprising 33,214 cases. Eur J Clin Microbiol Infect Dis 2016; 35: 1227-45
• 10 Fowler VGJr, Miro JM, Hoen B, Cabell CH, Abrutyn E. et al ICE Investigators Staphylococcus aureus endocarditis: A consequence of medical progress. JAMA 2005; 293: 3012-21
• 11 Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 2001; 14: 177-207
• 12 Millar BC, Moore JE. Emerging issues in infective endocarditis. Rev Biomed 2004; 15: 191-201
• 13 Purcell LK, Finley JP, Chen R, Lovgren S, Halperin SA. Gemella species endocarditis in a child. Can J Infect Dis 2001; 12: 317-20
• 14 Ukimura A, Nishihara S, Suwa M, Hirota Y, Kitaura Y, Kawamura K. et al. Prosthetic ball valve endocarditis due to Gemella species. Jpn Circ J 1998; 62: 626-8
• 15 Elsayed S, Zhang K. Gemella bergeriae endocarditis diagnosed by sequencing of rRNA genes in heart valve tissue. J Clin Microbiol 2004; 42: 4897-900
• 16 Kilpper-Bälz R, Schleifer KH. Transfer of Streptococcus morbillorum to the genus Gemella as Gemella morbillorum comb. nov. Int J Syst Evol Microbiol 1988; 38: 442-3
• 17 Facklam R, Elliott JA. Identification, classification, and clinical relevance of catalase-negative, gram-positive cocci, excluding the streptococci and enterococci. Clin Microbiol Rev 1995; 8: 479-95
• 18 Thjötta T, Böe J. Neisseria hemolysans. A hemolytie species of Neisseria trevisan. Acta Pathol Microbiol Scand 1938; 15: 527-31
• 19 Tunnicliff R. The cultivation of a micrococcus from blood in pre-eruptive and eruptive stages of measles. J Am Med Assoc 1971; 68: 1028-30
• 20 Berger U. A proposed new genus of gram-negative cocci: Gemella. Int J Syst Evol Microbiol 1961; 11: 17-9
• 21 Vasishtha S, Isenberg HD, Sood SK. Gemella morbillorum as a cause of septic shock. Clin Infect Dis 1996; 22: 1084-6
• 22 Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS. et al. Infective endocarditis epidemiology over five decades: A systematic review. PLoS One 2013; 8: e82665
• 23 Jiang Q, Liu J, Chen L, Gan N, Yang D. The oral microbiome in the elderly with dental caries and health. Front Cell Infect Microbiol 2018; 8: 442
• 24 Millan M, Merino S, Caro A, Feliu F, Escuder J, Francesch T, Sarin YK. Treatment of colorectal cancer in the elderly. World J Gastrointest Oncol 2015; 7: 204-20
• 25 Baghdadi J, Kelesidis T, Humphries R. In vitro susceptibility of Gemella species from clinical isolates. Open Forum Infect Dis 2015; 2: 1737
• 26 Buu-Hoï A, Sapoetra A, Branger C, Acar JF. Antimicrobial susceptibility of Gemella haemolysans isolated from patients with subacute endocarditis. Eur J Clin Microbiol 1982; 1: 102-6
• 27 Kuriyama T, Karasawa T, Nakagawa K, Yamamoto E, Nakamura S. Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections. Oral Microbiol Immunol 2002; 17: 132-5
• 28 Sexton DJ. Antimicrobial therapy of native valve endocarditis. UpToDate. Waltham, MA: UpToDate; 2014.
• 29 Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ. et al. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation 2015; 132: 1435-86
• 30 Lopez-Dupla M, Creus C, Navarro O, Raga X. Association of Gemella morbillorum endocarditis with adenomatous polyps and carcinoma of the colon: Case report and review. Clin Infect Dis 1996; 22: 379-80
• 31 Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012;6:320-9.
• 32 Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One 2012; 7: e39743
• 33 Flynn KJ, Baxter NT, Schloss PD. Metabolic and community synergy of oral bacteria in colorectal cancer. mSphere 2016; 1: e00102-16
• 34 Stroup JS, Bransteitter BA, Reust R. Infective endocarditis caused by Gemella species. Infect Dis Clin Pract 2007; 15: 203-5